文献速递瓣膜病与结构性心脏病心力衰竭与心肌病

经导管主动脉瓣置换术后舒张功能与临床结局:PARTNER 2 SAPIEN 3 注册研究

Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry.
PubMed 文献 · J Am Coll Cardiol · 2020-01-01

基于 PARTNER 2 SAPIEN 3 注册研究 1750 例接受 TAVR 的主动脉瓣狭窄患者,按 ASE 舒张功能障碍分级分析基线及术后超声心动图。基线 DD 分级递增与 1 年和 2 年心血管死亡/再住院及 2 年全因死亡相关;30 天 DD 分级改善/1 级 DD 与 1 年心血管死亡/再住院减少及 2 年生存改善相关。

要点

  • 基线舒张功能障碍分级越高,TAVR 后 1 年和 2 年心血管死亡/再住院风险越高。
  • 基线 3 级 DD 是 1 年心血管死亡/再住院的预测因素(HR 2.73,95%CI 1.07–6.98,P=0.04)。
  • 30 天 DD 分级改善/1 级 DD 对 1 年心血管死亡/再住院有保护作用(HR 0.39,95%CI 0.19–0.83,P=0.01)。

核心结论

  • 在 PARTNER 2 SAPIEN 3 注册研究中,基线舒张功能障碍可预测 TAVR 患者长达 2 年的临床结局。
  • TAVR 后 30 天舒张功能障碍分级改善与短期临床结局改善相关。

研究设计与样本

  • 分析 PARTNER 2 SAPIEN 3 注册研究中 1750 例接受 TAVR 的主动脉瓣狭窄患者的基线、30 天、1 年和 2 年经胸超声心动图。
  • 由核心实验室联合体分析超声心动图,并按美国超声心动图学会舒张功能障碍分组进行分组。

主要发现

  • 1750 例中,682 例(54.4%)为 1 级 DD,352 例(28.1%)为 2 级 DD,168 例(13.4%)为 3 级 DD,51 例(4.1%)为不确定分级。
  • 基线 DD 分级递增与 1 年和 2 年心血管死亡/再住院增加相关(所有 P<0.002),并与 2 年全因死亡相关(P=0.01),但与 1 年全因死亡无关。
  • TAVR 后 30 天,70.8% 患者出现 DD 分级改善/1 级 DD。
  • DD 分级改善≥1 级/1 级 DD 的患者 1 年心血管死亡/再住院减少(P<0.001),2 年生存增加(P=0.01)。
  • 基线 3 级 DD 是 1 年心血管死亡/再住院的预测因素(HR 2.73,95%CI 1.07–6.98,P=0.04)。

临床怎么用

  • 对接受 TAVR 的主动脉瓣狭窄患者,应评估基线舒张功能障碍分级以辅助风险分层。
  • TAVR 后 30 天复查超声心动图评估舒张功能障碍分级变化,可能有助于判断短期预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Few studies have evaluated if diastolic function could predict outcomes in patients with aortic stenosis. OBJECTIVES: The authors aimed to assess the association between diastolic dysfunction (DD) and outcomes in patients with aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). METHODS: Baseline, 30-day, and 1- and 2-year transthoracic echocardiograms from the PARTNER (Placement of Aortic Transcatheter Valves) 2 SAPIEN 3 registry were analyzed by a consortium of core laboratories and divided into the American Society of Echocardiography DD groups. RESULTS: Among the 1,750 included, 682 (54.4%) had grade 1 DD, 352 (28.1%) had grade 2 DD, 168 (13.4%) had grade 3 DD, and 51 (4.1%) had indeterminate DD grade. Incremental baseline grades of DD were associated with an increase in combined 1- and 2-year cardiovascular (CV) death/rehospitalization (all p < 0.002) and all-cause death at 2 years (p = 0.01) but not at 1 year. Improvement in DD grade/grade 1 DD at 30 days post-TAVR was seen in 70.8% patients. Patients with improvement in ≥1 grade of DD/grade 1 DD had reduced 1-year CV death/rehospitalization (p < 0.001) and increased 2-year survival (p = 0.01). Baseline grade 3 DD was a predictor of 1-year CV death/rehospitalization (hazard ratio: 2.73; 95% confidence interval: 1.07 to 6.98; p = 0.04). Improvement in DD grade/grade 1 DD at 30 days was protective for 1-year CV death/rehospitalizations (hazard ratio: 0.39; 95% confidence interval: 0.19 to 0.83; p = 0.01). CONCLUSIONS: In the PARTNER 2 SAPIEN 3 registry, baseline DD was a predictor of up to 2 years clinical outcomes in patients who underwent TAVR. Improvement in DD grade at 30 days was associated with improvement in short-term clinical outcomes. (The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - PARTNERII - S3 Intermediate [PARTNERII S3i]; NCT03222128; PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - High Risk and Nested Registry 7 [PII S3HR/NR7]; NCT03222141).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Ong G, Pibarot P, Redfors B, et al. Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry. J Am Coll Cardiol. 2020. PMID: 33334422. doi:10.1016/j.jacc.2020.10.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。